Notes52 Weeks
Ended
2 December
2018
£m
53 Weeks
Ended
3 December
2017
Restated*
£m
Revenue2.2, 2.3, 2.41,598.81,454.5
Cost of sales(1,051.3)(959.5)
Gross profit547.5495.0
Other income2.571.961.0
Distribution costs(485.4)(434.2)
Administrative expenses(167.0)(117.7)
Operating (loss)/profit before result from joint venture and exceptional itemsA(33.0)4.1
Share of result from joint venture3.51.21.6
Exceptional itemsA2.8(0.1)(0.3)
Operating (loss)/profit2.6(31.9)5.4
Finance income4.52.20.2
Finance costs4.5(14.7)(13.9)
Loss before tax(44.4)(8.3)
Taxation2.9(0.5)
Loss for the period(44.9)(8.3)
Loss per sharepencepence
Basic and diluted loss per share2.10(6.85)(1.38)

Non-GAAP measure: Earnings before interest, taxation, depreciation, amortisation, impairment and exceptional items (EBITDA)A

Notes52 Weeks
Ended
2 December
2018
£m
53 Weeks
Ended
3 December
2017
Restated*
£m
Operating (loss)/profit(31.9)5.4
Adjustments for:
Depreciation of property, plant and equipment3.263.355.0
Amortisation expense3.127.115.4
Impairment of property, plant and equipment3.20.50.4
Impairment of intangible assets3.10.40.2
Exceptional itemsA – other2.80.10.3
EBITDAA59.576.7

*2017 restatement was due to the adoption of IFRS 15 during the year. Refer to note 1.5 for further details.

The Notes to the Consolidated Financial Statements form part of these financial statements.